Japanese drugmaker Takeda's QDENGA has become India's first approved dengue vaccine, offering protection against all four virus serotypes without requiring pre-vaccination testing.
QDENGA is a live-attenuated tetravalent vaccine
Jul 20, 2026
02:37 pm
What's the storyTakeda Pharmaceutical's dengue vaccine, QDENGA, has been approved by India's drug regulator.
This marks a historic milestone as QDENGA becomes the first-ever dengue vaccine to get the green light in India.
QDENGA, India's first dengue vaccine, receives approval for use, marking a significant milestone in dengue prevention efforts.
QDENGA can be administered to individuals irrespective of previous dengue exposure, without requiring pre-vaccination testing.
Japanese drug firm Takeda Biopharmaceuticals has received market authorisation from the Drug Controller General of India (DCGI)…
Takeda's QDENGA is India's first dengue vaccine approved for use regardless of prior exposure, enhancing disease prevention…
India's drug regulator has approved Takeda's Qdenga dengue vaccine, the first of its kind. This vaccine is expected to become…
India approves Takeda's QDENGA dengue vaccine for ages 4-60, offering protection against all virus serotypes without prior…
Japanese firm’s dengue vaccine becomes first to get regulatory approval in India
